JUNGHEE CHE: Open Payments
NPI 1144510884 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,189 in 276 payments from 27 companies in 2025. Trend: 2023 $4,354 · 2024 $5,759 · 2025 $6,189
Food & beverage: $6,169Education: $21
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,591 |
| AstraZeneca Pharmaceuticals LP | 22 | $850 |
| MAYNE PHARMA COMMERCIAL LLC | 47 | $787 |
| Corcept Therapeutics | 13 | $352 |
| Phathom Pharmaceuticals, Inc. | 8 | $278 |
| Otsuka America Pharmaceutical, Inc. | 10 | $271 |
| Amgen Inc. | 21 | $242 |
| GlaxoSmithKline, LLC. | 15 | $237 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $235 |
| Lilly USA, LLC | 5 | $206 |
Products named: BREZTRI, JARDIANCE, Korlym, QULIPTA, LINZESS, REXULTI, VRAYLAR, CREON.
Industry payments across WA — which companies pay providers there.
